Medical Condition News

RSS

NIDA announces winners of Avant-Garde Awards for Innovative Medication Development Research

Scientists proposing to develop vaccines against methamphetamine and nicotine have been selected to receive NIDA's second Avant-Garde Awards for Innovative Medication Development Research.

22 Sep 2011

NIH-funded project to develop new class of tissue regeneration therapeutics

The National Institutes of Health (NIH) has awarded nearly $2 million to researchers at the Georgia Institute of Technology and Emory University to develop a new class of therapeutics for treating traumatic injuries and degenerative diseases.

22 Sep 2011

Scientists identify stress receptor that stimulates growth and migration of cancer cells

It's a common belief that there's a link between chronic stress and an increased risk of cancer. In new research published online by the International Journal of Cancer, scientists at The University of Western Ontario have taken a step toward confirming that belief.

22 Sep 2011

Study confirms biphasic nature of alcohol's effect on progression of atherosclerosis

An excellent study among experimental mice has reported very dramatic differences between the effects of alcohol administered in moderation on a daily basis and the same total weekly amount of alcohol administered on only two days of the week: (replicating binge drinking).

21 Sep 2011

African Americans more likely than Caucasians to develop and die from lung cancer

Lung cancer, the leading cause of cancer death in the U.S., takes a particularly heavy toll on African Americans. Despite their lower smoking rates, African Americans are more likely than Caucasians to develop and die from lung cancer.

21 Sep 2011

Study assesses impact of ethnicity on second-line treatment of non-small cell lung cancer

Racial and ethnic minorities are more likely to develop cancer and die from it than the general U.S. population. However, as the next generation of cancer medicines are being evaluated, only 17 percent of clinical trial participants are, in fact, minorities.

21 Sep 2011

Saladax, Bristol-Myers Squibb expand Alzheimer's diagnostic assays agreement

Bristol-Myers Squibb Company and Saladax Biomedical, Inc., announced today they have expanded their multi-year agreement covering the development and commercialization of diagnostic assays for the early detection of Alzheimer's disease to include Ortho-Clinical Diagnostics, Inc.

21 Sep 2011

AACR releases landmark Cancer Progress Report 2011

The American Association for Cancer Research (AACR), today will release its AACR Cancer Progress Report 2011, in which its calls on Congress to increase funding for the National Institutes of Health (NIH) and the National Cancer Institute.

21 Sep 2011

Long-term immunosuppressants improve survival for lupus patients with ESKD

Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease—a finding that could reverse long-standing clinical practice.

21 Sep 2011

Study examines link between gestational age at birth and mortality in young adulthood

In a study that included more than 600,000 individuals born in Sweden between 1973-1979, those born preterm had a higher risk of death during early childhood and young adulthood than persons born at term, according to a study in the September 21 issue of JAMA.

21 Sep 2011

HRPR before PCI procedures linked to increased risk of ischemic event in ACS patients

Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine appropriate clopidogrel dosing and who had high residual platelet reactivity were at an increased risk of an ischemic event at short- and long-term follow-up of up to 2 years, according to a study in the September 21 issue of JAMA.

21 Sep 2011

Isolating 'bad' cells in rodent experiments may hold key to improving treatment for heart attacks

A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.

21 Sep 2011

GI Dynamics introduces EndoBarrier Gastrointestinal Liner in Austria

GI Dynamics, Inc. today announced the launch of the EndoBarrier Gastrointestinal Liner in Austria, the establishment of the first two Centers of Excellence and the treatment of patients at each new Center.

21 Sep 2011

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that in a rodent contusion model of SCI the Company's proprietary biopolymer scaffold showed positive preliminary data that indicate a therapeutic effect.

21 Sep 2011

NUI Galway researchers develop super-sized model of heart valve

Researchers at NUI Galway have developed a super-sized model of a heart valve which may lead to a new generation of cardiovsacular devices.

21 Sep 2011

Free public lecture to reveal new insights into brain cells linked with stroke, cerebral palsy

A free public lecture at the University of Leicester is to discuss how the white matter of the brain could be the key to understanding and treating brain disorders - not grey matter as previously thought.

21 Sep 2011

Gothenburg researcher advises patients with acute low back pain to stay active

Move if you have back pain, this is the advice of a researcher at the Sahlgrenska Academy, University of Gothenburg. Patients with acute low back pain who were advised to stay active despite the pain fared better than those who were told to adjust their activity in line with their pain.

21 Sep 2011

Clinical trial to evaluate TAU's stem cell technology for ALS

The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

21 Sep 2011

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

Boehringer Ingelheim today announced enrolment has commenced in its TOviTO Phase III clinical trial program. It will investigate tiotropium plus olodaterol in a once-daily fixed-dose combination for the treatment of chronic obstructive pulmonary disease.

21 Sep 2011

Foreign Affairs examines history of negotiations on NCD political declaration

Foreign Affairs on Tuesday published an analysis examining the history of negotiations behind the political declaration approved on Monday by leaders attending the U.N. High-level Meeting on Non-Communicable Diseases.

21 Sep 2011

Medical Condition News

NIDA announces winners of Avant-Garde Awards for Innovative Medication Development Research

NIH-funded project to develop new class of tissue regeneration therapeutics

Scientists identify stress receptor that stimulates growth and migration of cancer cells

Study confirms biphasic nature of alcohol's effect on progression of atherosclerosis

African Americans more likely than Caucasians to develop and die from lung cancer

Study assesses impact of ethnicity on second-line treatment of non-small cell lung cancer

Saladax, Bristol-Myers Squibb expand Alzheimer's diagnostic assays agreement

AACR releases landmark Cancer Progress Report 2011

Long-term immunosuppressants improve survival for lupus patients with ESKD

Study examines link between gestational age at birth and mortality in young adulthood

HRPR before PCI procedures linked to increased risk of ischemic event in ACS patients

Isolating 'bad' cells in rodent experiments may hold key to improving treatment for heart attacks

GI Dynamics introduces EndoBarrier Gastrointestinal Liner in Austria

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

NUI Galway researchers develop super-sized model of heart valve

Free public lecture to reveal new insights into brain cells linked with stroke, cerebral palsy

Gothenburg researcher advises patients with acute low back pain to stay active

Clinical trial to evaluate TAU's stem cell technology for ALS

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

Foreign Affairs examines history of negotiations on NCD political declaration

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News